These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 32369451

  • 1. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N, Martins C, Darrigade AS, Drullion C, Rambert J, Barrault C, Garnier J, Jacquemin C, Thiolat D, Lucchese F, Morel F, Ezzedine K, Taieb A, Bernard FX, Seneschal J, Boniface K.
    JCI Insight; 2020 Jun 04; 5(11):. PubMed ID: 32369451
    [Abstract] [Full Text] [Related]

  • 2. Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment.
    Bzioueche H, Boniface K, Drullion C, Marchetti S, Chignon-Sicard B, Sormani L, Rocchi S, Seneschal J, Passeron T, Tulic MK.
    Br J Dermatol; 2023 Aug 24; 189(3):312-327. PubMed ID: 37140010
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
    Cario-André M, Pain C, Gauthier Y, Taïeb A.
    Pigment Cell Res; 2007 Oct 24; 20(5):385-93. PubMed ID: 17850512
    [Abstract] [Full Text] [Related]

  • 6. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
    Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D.
    Histol Histopathol; 2009 Jul 24; 24(7):849-57. PubMed ID: 19475531
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo.
    Singh M, Mansuri MS, Kadam A, Palit SP, Dwivedi M, Laddha NC, Begum R.
    Cytokine; 2021 Apr 24; 140():155432. PubMed ID: 33517195
    [Abstract] [Full Text] [Related]

  • 11. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
    Willemsen M, Krebbers G, Tjin EPM, Willemsen KJ, Louis A, Konijn VAL, Narayan VS, Post NF, Bakker WJ, Melief CJM, Bekkenk MW, Luiten RM.
    Exp Dermatol; 2022 Apr 24; 31(4):556-566. PubMed ID: 34758170
    [Abstract] [Full Text] [Related]

  • 12. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
    Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P.
    Pigment Cell Res; 2002 Apr 24; 15(2):87-92. PubMed ID: 11936274
    [Abstract] [Full Text] [Related]

  • 13. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
    Ng CY, Chan YP, Chiu YC, Shih HP, Lin YN, Chung PH, Huang JY, Chen HK, Chung WH, Ku CL.
    J Dermatol Sci; 2023 Jun 24; 110(3):78-88. PubMed ID: 37221109
    [Abstract] [Full Text] [Related]

  • 14. Melanocyte Adhesion and Apoptosis in Vitiligo: Linking Puzzle Blocks.
    Srivastava N, Gupta S, Parsad D.
    Curr Mol Med; 2023 Jun 24; 23(8):709-711. PubMed ID: 35726816
    [Abstract] [Full Text] [Related]

  • 15. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
    Kumar R, Parsad D, Kanwar AJ, Kaul D.
    Br J Dermatol; 2011 Aug 24; 165(2):285-91. PubMed ID: 21428970
    [Abstract] [Full Text] [Related]

  • 16. Melanocyte-keratinocyte cross-talk in vitiligo.
    Touni AA, Shivde RS, Echuri H, Abdel-Aziz RTA, Abdel-Wahab H, Kundu RV, Le Poole IC.
    Front Med (Lausanne); 2023 Aug 24; 10():1176781. PubMed ID: 37275386
    [Abstract] [Full Text] [Related]

  • 17. A New View of Vitiligo: Looking at Normal-Appearing Skin.
    Picardo M, Bastonini E.
    J Invest Dermatol; 2015 Jul 24; 135(7):1713-1714. PubMed ID: 26066890
    [Abstract] [Full Text] [Related]

  • 18. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
    Gauthier Y, Cario Andre M, Taïeb A.
    Pigment Cell Res; 2003 Aug 24; 16(4):322-32. PubMed ID: 12859615
    [Abstract] [Full Text] [Related]

  • 19. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG, Maraee AH, Shoeib MA, Elbana R.
    Appl Immunohistochem Mol Morphol; 2012 Oct 24; 20(5):501-11. PubMed ID: 22495383
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM, Asghar SS, Pijnenborg AC, Tigges AJ, Westerhof W, Das PK.
    Br J Dermatol; 2002 Jan 24; 146(1):80-7. PubMed ID: 11841370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.